Edesa Biotech, Inc. — Form D

Edesa Biotech, Inc. of MARKHAM, A6, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-21. The offering totals $6.8M, of which $6.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
Gregory T BaxterDirectorPort Hueneme, CA
Tessie M CheDirectorPort Hueneme, CA
David Louis HillDirectorPort Hueneme, CA
DANIEL E MORSEDirectorPORT HUENEME, CA
FRANK R OAKESDirectorPORT HUENEME, CA
Mayank D SampatDirectorPort Hueneme, CA
Mary Catherine BrissonExecutive OfficerPort Hueneme, CA
Mark A McPartlandExecutive OfficerSouth San Francisco, CA
Kathi Catherine NiffeneggerExecutive OfficerPort Hueneme, CA
FRANK R OAKESExecutive OfficerPORT HUENEME, CA
Jennifer ChaoDirectorOakville, A6
Patrick MarshallDirectorMarkham, A6
Patrick MarshallRelated PersonMarkham, A6
Sean MacDonaldDirectorMarkham, A6
Sean MacDonaldRelated PersonMarkham, A6
Pardeep NijhawanDirectorMarkham, A6
Pardeep NijhawanExecutive OfficerMarkham, A6
Pardeep NijhawanRelated PersonMarkham, A6
Stephen LemieuxExecutive OfficerMARKHAM, A6
Charles OlsonDirectorMarkham, A6
Charles OlsonRelated PersonMarkham, A6
Frank OakesDirectorMARKHAM, A6
David LiuDirectorMarkham, A6
David LiuRelated PersonMarkham, A6
Joan ChypyhaDirectorMarkham, A6

Other filings by this issuer (8)

FiledFormOfferingSold
2026-06-26D$3.5M$3.5M
2025-02-14D$15.0M$15.0M
2022-04-05D
2013-10-03D/A$12.0M$12.0M
2013-09-03D$12.0M
2013-04-11D$1.6M$1.6M
2013-01-15D$505K$505K
2012-10-31D$1.0M$1.0M

More